Stress-Blocking drug combo may boost melanoma immunotherapy
Disease control
Recruiting now
This early-phase study tests whether adding two common drugs—naltrexone and propranolol—to standard immunotherapy can safely help control advanced melanoma. The drugs target stress pathways that may weaken the immune system's ability to fight tumors. About 12 adults with advanced…
Phase: PHASE1 • Sponsor: Sarah Weiss • Aim: Disease control
Last updated May 13, 2026 15:59 UTC